Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases

E-ISSN： 1873-4286|13|8|845-863

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.8, 2007-03, pp. : 845-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Protecting Endothelium in Cardiovascular Diseases

Current Medicinal Chemistry, Vol. 21, Iss. 25, 2014-08 ,pp. : 2989-3006

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Mitochondria in Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 22, Iss. 37, 2016-11 ,pp. : 5698-5717

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 21, Iss. 30, 2015-10 ,pp. : 4392-4399

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases

By Parajuli Nirmal Ramprasath Tharmarajan Patel Vaibhav B. Wang Wang Putko Brendan Mori Jun Oudit Gavin Y.

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 558-565

NRC Research Press

Access to resources Recommend Favorite

Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?

By Dessolin J. Schuler M. Quinart A. De Giorgi F. Ghosez L. Ichas F.

European Journal of Pharmacology, Vol. 447, Iss. 2, 2002-07 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite